GALIMBERTI, CARLO ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 522
EU - Europa 313
AS - Asia 249
SA - Sud America 3
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.091
Nazione #
US - Stati Uniti d'America 521
CN - Cina 205
IE - Irlanda 178
FI - Finlandia 50
SG - Singapore 31
DE - Germania 23
IT - Italia 21
UA - Ucraina 17
SE - Svezia 6
GB - Regno Unito 5
IN - India 5
BE - Belgio 3
PL - Polonia 3
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
FR - Francia 2
JP - Giappone 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
CA - Canada 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
LU - Lussemburgo 1
RU - Federazione Russa 1
UZ - Uzbekistan 1
Totale 1.091
Città #
Dublin 178
Chandler 152
Nanjing 59
Beijing 45
Jacksonville 42
Ashburn 38
Boardman 29
Singapore 28
Helsinki 26
Wilmington 23
Lawrence 22
Medford 22
Princeton 22
Shanghai 19
Changsha 18
Nanchang 17
Jiaxing 12
New York 12
Ann Arbor 11
Shenyang 8
Hangzhou 7
Chicago 6
Tianjin 6
Hebei 5
Los Angeles 5
Pavia 5
Rome 5
Woodbridge 5
Brussels 3
Norwalk 3
Radom 3
Washington 3
Chanhassen 2
Dallas 2
London 2
Mantova 2
Melbourne 2
Pune 2
Sutri 2
Taizhou 2
Tokyo 2
Algiers 1
Baku 1
Berlin 1
Buenos Aires 1
Charlotte 1
Dearborn 1
Des Moines 1
Dubai 1
Fairfield 1
Falkenstein 1
Fuzhou 1
Guangzhou 1
Hamburg 1
Houston 1
Izhevsk 1
Luxembourg 1
Markham 1
Milan 1
Munich 1
Nanyang 1
New Delhi 1
Orange 1
Palermo 1
Phoenix 1
Redwood City 1
San Francisco 1
Seattle 1
Shenzhen 1
Stanton 1
Tashkent 1
Tbilisi 1
Yerevan 1
Zanjan 1
Zurich 1
Totale 891
Nome #
Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. 85
A multiparametric investigation of daytime sleepiness and psychomotor functions in epileptic patients treated with phenobarbital and sodium valproate: a comparative controlled study 70
Focal epileptic seizures mimicking sleep paralysis 66
COMORBIDITY BETWEEN SLEEP PARALYSIS AND EPILEPSY 63
Parahippocampal Involvement in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis: A Proof of Concept from Memory-Guided Saccades 59
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.SOPHIE Study Group. 58
Daytime sleepiness in healthy university students: A multiparametric study 56
A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy 55
Antiepileptic drug use and epileptic seizures in nursing home residents in the Province of Pavia, Italy: A reappraisal 12 years after a first survey 55
Strabismo parossistico: Meccanismi corticali e meccanismi periferici nella fisiopatologia di due casi con analoga fenomenologia critica 54
Comparative pharmacokinetics and pharmacodynamics of eterobarbital and phenobarbital in normal volunteers. 53
Memory guided saccades in mesial temporal lobe epilepsy with hippocampal scelrosis. 52
DIFFERENTIAL-EFFECTS OF VALPROIC ACID AND ENZYME-INDUCING ANTICONVULSANTS ON NIMODIPINE PHARMACOKINETICS IN EPILEPTIC PATIENTS 47
Relation between arousal and focal epileptic seizure during sleep: Evaluation by CAP analysis 47
Daytime sleepiness in epileptic patients on long-term monotherapy: MSLT, clinical and psychometric assessment 44
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial 39
Validated outcome of treatment changes according to International League Against Epilepsy criteria in adults with drug-resistant focal epilepsy 38
Epileptic seizures and antiepileptic drug use in elderly nursing home residents 38
Rare sleep-related convulsive seizures in elderly subjects 38
Obstructive sleep apnea in a clinical series of adult epilepsy patients: Frequency and features of the comorbidity 38
The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid. 33
Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy 27
Novel CLN3 mutation causing autophagic vacuolar myopathy 10
Totale 1.125
Categoria #
all - tutte 5.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 0 0 0 0 0 3 1 4 0 18 35 1
2020/202158 6 4 1 4 0 6 6 12 4 9 5 1
2021/202292 2 1 0 0 1 0 2 4 11 0 11 60
2022/2023430 38 38 9 37 20 49 2 23 205 0 5 4
2023/2024157 28 32 6 12 9 38 5 9 1 7 5 5
2024/202591 15 25 32 10 9 0 0 0 0 0 0 0
Totale 1.125